Académique Documents
Professionnel Documents
Culture Documents
The global Indirect ELISA market is valued at USD XX million in 2016 and is
expected to reach USD XX million by the end of 2022, growing at a CAGR of
XX% between 2016 and 2022.
North America
Europe
China
Japan
Southeast Asia
India
R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMrieux
EMD Millipore
BioLegend
LOEWE Biochemica
Request Sample Copy @ https://www.reportsmonitor.com/request-
sample/?post=98771
On the basis of product, this report displays the production, revenue, price,
market share and growth rate of each type, primarily split into
ELISA Sets
ELISA Kits
On the basis on the end users/applications, this report focuses on the status
and outlook for major applications/end users, consumption (sales), market
share and growth rate of Indirect ELISA for each application, including
Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Other
Table of Contents
1.2.1 Global Indirect ELISA Production and CAGR (%) Comparison by Type (Product
Category) (2012-2022)
1.2.2 Global Indirect ELISA Production Market Share by Type (Product Category) in
2016
1.3.2 Immunology
1.3.3 Inflammation
1.3.5 Cancer
1.3.7 Other
1.4.1 Global Indirect ELISA Market Size (Value) and CAGR (%) Comparison by
Region (2012-2022)
1.5.2 Global Indirect ELISA Capacity, Production Status and Outlook (2012-2022)
Contact Us
Jay Mathews
Email: sales@reportsmonitor.com
Website: www.reportsmonitor.com
Follow Us: